Helvetica Chimica Acta Vol. 86 (2003)
3581
Synthesis of l-Talopyranose. Preparation of (Z)-a,b-unsaturated ester 11 was
carried out by treatment of aldehyde 4 with bis(2,2,2-trifluoroethyl)(methoxycar-
bonylmethyl)phosphonate (CF3CH2O)2POCH2CO2Me (Horner Emmons condition)
in the presence of 18-crown-6 and KN(TMS)2 in THFat À788 to afford 11 in 85% yield
(Scheme 4). Although (Z)-configured alkenes are reported to give higher levels of anti-
selectivity than (E)-isomers [6], the same oxidation conditions used for the preparation
of 6 provided a mixture of pentols 12a and 12b with a rather disappointing anti/syn ratio
of 2.3 :1 in 87% yield. The major anti-diastereoisomer was separated from its syn-
diastereoisomer with ease by silica-gel chromatography, affording the pure anti-12a in
54% yield. The desired diastereoisomer 12a was converted to the fully protected pentol
ester 13 that was, in turn, reduced to the aldehyde 14 with DIBAL in toluene at À788
(77% yield for two steps). Formation of the pyranose system was accomplished by
treatment of 14 with catalytic amount of TFA in CH2Cl2 at 08 for 3 h, followed by
acetylation. The last two-step sequence provided the l-talopyranose derivative 15 as a
single b-anomer in 60% yield2).
Scheme 4. Synthesis of 1,2,3,6-Tetra-O-acetyl-4-O-[(tert-butyl)diphenylsilyl]-l-talopyranose 15
a) (CF3CH2O)2POCH2CO2CH3, 18-crown-6, KN(TMS)2, THF, À788; 85%. b) OsO4 (cat.), NMO, THF, 90 h;
54% (anti-14). c) Me2C(OMe)2, TsOH (cat.), acetone; 85%. d) (Me2CHCH2)2AlH, toluene, À788; 95%. e)
TFA/CH2Cl2, 08, 15 min. f) Ac2O, Et3N, 4-(dimethylamino)pyridine, CH2Cl2; 60% from 14.
Conclusions. We have developed an expedient route to asymmetric synthesis of l-
hexoses starting from the ascorbic acid-derived ester 1. The versatility of our method
for the syntheses of the different l-hexopyranoses is demonstrated simply by changing
the reagents used for the preparation of (E)- and (Z)-a,b-unsaturated esters, 5 and 11,
respectively. Furthermore, it is noteworthy that stereoselective dihydroxylation of the
2
)
Data for l-talopyranose 15: [a]D 24.8 (c 1.6): IR (neat): 3481, 3073, 3019, 2934, 2860, 1755, 1473,
1428, 1370, 1228, 1138, 1113, 1073, 925, 822, 757, 704, 667, 611. 1H-NMR 7.65 (m, 4 H); 7.40 (m, 6 H); 5.95
(d, J 7.3, HÀC(1)); 5.37 (d, J 3.2, HÀC(2)); 5.33 (dd, J 3.2, 7.7, HÀC(3)); 4.20 (dd, J 7.9, 11.1,
HÀC(6)); 4.05 (ddd, J 1.3, 4.3, 7.6, HÀC(5)); 3.95 (dd, J 4.3, 11.1, HÀC(6)); 3.82 (dd, J 1.3, 4.3,
HÀC(4)); 2.15 (s, 3 H); 1.97 (s, 3 H); 1.92 (s, 6 H), 1.13 (s, 9 H): 13C-NMR: 170.5; 169.2; 136.1; 132.1; 130.2;
130.1; 127.9; 90.4 (C(1)); 73.4 (C(5)); 69.9 (C(2)); 68.7 (C(4)); 67.5 (C(3)); 63.1 (C(6)); 27.1; 27.0; 21.1; 21.4;
20.8; 20.7; 20.6; 19.5. ESI-MS: 609 ([M Na] ).